Shanghai Research Institute of Pharmaceutical Industry

The Shanghai Research Institute of Pharmaceutical Industry (SRIPI) is a premier comprehensive pharmaceutical research and development institution based in China. Founded in 1957 and currently a core subsidiary of the China National Pharmaceutical Group (Sinopharm), SRIPI serves as a critical hub for drug innovation and industrialization. The institute's expertise spans chemical drug synthesis, modern biotechnology, and advanced pharmaceutical formulations. It operates multiple national key laboratories and provides a wide array of services, including contract research, process development, and manufacturing support. SRIPI has been instrumental in the development of hundreds of pharmaceutical products, significantly contributing to the growth of both domestic and international healthcare markets.